News
ACH
2.570
+1.18%
0.030
Weekly Report: what happened at ACH last week (0330-0403)?
Weekly Report · 2d ago
Weekly Report: what happened at ACH last week (0323-0327)?
Weekly Report · 03/30 10:18
Weekly Report: what happened at ACH last week (0316-0320)?
Weekly Report · 03/23 10:15
Weekly Report: what happened at ACH last week (0309-0313)?
Weekly Report · 03/16 10:14
Is the Options Market Predicting a Spike in Accendra Health Stock?
NASDAQ · 03/13 12:30
Weekly Report: what happened at ACH last week (0302-0306)?
Weekly Report · 03/09 10:14
Weekly Report: what happened at ACH last week (0223-0227)?
Weekly Report · 03/02 10:13
Weekly Report: what happened at ACH last week (0216-0220)?
Weekly Report · 02/23 10:13
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade)
Seeking Alpha · 02/20 23:30
Accendra Health Is Maintained at Market Perform by Leerink Partners
Dow Jones · 02/20 21:54
Accendra Health Price Target Cut to $2.75/Share From $3.00 by Leerink Partners
Dow Jones · 02/20 21:54
Leerink Partners Maintains Market Perform on Accendra Health, Lowers Price Target to $2.75
Benzinga · 02/20 21:44
Accendra Health, Inc. Common Stock Q4 Adj. EPS $0.21 Misses $0.22 Estimate, Sales $708.967M Miss $714.733M Estimate
Benzinga · 02/19 21:07
Here are the major earnings after the close Thursday
Seeking Alpha · 02/19 15:00
Earnings Scheduled For February 19, 2026
Benzinga · 02/19 11:11
Weekly Report: what happened at ACH last week (0209-0213)?
Weekly Report · 02/16 10:13
Weekly Report: what happened at ACH last week (0202-0206)?
Weekly Report · 02/09 10:15
Press Release: Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
Dow Jones · 02/05 22:12
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio
The Motley Fool · 02/05 06:35
More
Webull provides a variety of real-time ACH stock news. You can receive the latest news about Accendra Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About ACH
Accendra Health, Inc., formerly Owens & Minor, Inc., is a nationwide pure play home-based care platform. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.